96 related articles for article (PubMed ID: 10230856)
1. Chronic hepatitis in interferon-gamma transgenic mice is associated with elevated CPP32-like activity and interleukin-1beta-converting enzyme activity suppression.
Okamoto T; Nakano Y; Yamakawa T; Hara K; Yamamura KI; Hino O
Jpn J Pharmacol; 1999 Mar; 79(3):289-94. PubMed ID: 10230856
[TBL] [Abstract][Full Text] [Related]
2. The mouse interferon-gamma transgene chronic hepatitis model (Review).
Okamoto T; Yamamura K; Hino O
Int J Mol Med; 1999 May; 3(5):517-20. PubMed ID: 10202184
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha gene expression in the liver of the IFN-gamma transgenic mouse with chronic active hepatitis.
Okamoto T; Furuya M; Yamakawa T; Yamamura K; Hino O
Biochem Biophys Res Commun; 1996 Sep; 226(3):762-8. PubMed ID: 8831687
[TBL] [Abstract][Full Text] [Related]
4. Induction of Fas ligand and Fas antigen mRNA expressions in interferon-gamma transgenic mouse liver.
Okamoto T; Yamakawa T; Yamamura K; Hino O
Jpn J Pharmacol; 1998 Oct; 78(2):233-5. PubMed ID: 9829628
[TBL] [Abstract][Full Text] [Related]
5. Induction of CPP32-like activity and inhibition of interleukin 1beta converting enzyme activity in the liver of a mouse concanavalin A-induced hepatitis model.
Okamoto T; Kobayashi T; Tsuzuike N; Hara K
Jpn J Pharmacol; 1998 Jul; 77(3):257-9. PubMed ID: 9717774
[TBL] [Abstract][Full Text] [Related]
6. Expression of the inducible form of the nitric oxide synthase gene in the livers of mice with chronic hepatitis.
Okamoto T; Yamamura K; Hino O
Int J Mol Med; 2000 Sep; 6(3):315-7. PubMed ID: 10934296
[TBL] [Abstract][Full Text] [Related]
7. Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.
Lian F; Wang Y; Xiao Y; Wu X; Xu H; Liang L; Yang X
Mol Med Rep; 2015 Oct; 12(4):5821-7. PubMed ID: 26238153
[TBL] [Abstract][Full Text] [Related]
8. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.
Toyonaga T; Hino O; Sugai S; Wakasugi S; Abe K; Shichiri M; Yamamura K
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):614-8. PubMed ID: 8290572
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma.
Fujikawa K; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Takase K; Nakano T
Anticancer Res; 2000; 20(3B):1927-32. PubMed ID: 10928128
[TBL] [Abstract][Full Text] [Related]
10. Effects of specific interleukin-1beta-converting enzyme inhibitor on ischemic acute renal failure in murine models.
Liu HF; Liang D; Wang LM; Zhou N; Yao CW; Hong T; Tang DS; Chen XW
Acta Pharmacol Sin; 2005 Nov; 26(11):1345-51. PubMed ID: 16225757
[TBL] [Abstract][Full Text] [Related]
11. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.
Mignon A; Rouquet N; Fabre M; Martin S; Pagès JC; Dhainaut JF; Kahn A; Briand P; Joulin V
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1308-15. PubMed ID: 10194182
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase mRNA in the livers of mice with interferon-gamma chronic hepatitis.
Okamoto T; Yamamura K; Hino O
Jpn J Pharmacol; 2000 Aug; 83(4):359-61. PubMed ID: 11001185
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha-induced apoptosis in olfactory epithelium in vitro: possible roles of caspase 1 (ICE), caspase 2 (ICH-1), and caspase 3 (CPP32).
Suzuki Y; Farbman AI
Exp Neurol; 2000 Sep; 165(1):35-45. PubMed ID: 10964483
[TBL] [Abstract][Full Text] [Related]
14. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
15. Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes.
Inayat-Hussain SH; Couet C; Cohen GM; Cain K
Hepatology; 1997 Jun; 25(6):1516-26. PubMed ID: 9185777
[TBL] [Abstract][Full Text] [Related]
16. Wild-type p53-dependent etoposide-induced apoptosis mediated by caspase-3 activation in human glioma cells.
Yin D; Tamaki N; Kokunai T
J Neurosurg; 2000 Aug; 93(2):289-97. PubMed ID: 10930016
[TBL] [Abstract][Full Text] [Related]
17. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis.
Hasegawa J; Kamada S; Kamiike W; Shimizu S; Imazu T; Matsuda H; Tsujimoto Y
Cancer Res; 1996 Apr; 56(8):1713-8. PubMed ID: 8620480
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice.
Okamoto T
Eur J Pharmacol; 2000 Jan; 387(2):229-32. PubMed ID: 10650164
[TBL] [Abstract][Full Text] [Related]
20. Correlation of glutamate-induced apoptosis with caspase activities in cultured rat cerebral cortical neurons.
Hirashima Y; Kurimoto M; Nogami K; Endo S; Saitoh M; Ohtani O; Nagata T; Muraguchi A; Takaku A
Brain Res; 1999 Dec; 849(1-2):109-18. PubMed ID: 10592292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
